• Users Online: 184
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2021  |  Volume : 23  |  Issue : 3  |  Page : 107-111

Bone marrow failure disease and head-and-neck squamous cell carcinoma in king faisal specialist hospital and research center in Riyadh


1 Otorhinolaryngology Head and Neck Surgery Consultant at King Faisal Specialist Hospital and Research in Riyadh; Otorhinolaryngology Head and Neck Surgery Residency Training Program Director at King Faisal Specialist Hospital and Research in Riyadh, Riyadh, Saudi Arabia
2 Senior Resident in Otorhinolaryngology Head and Neck Surgery Residency Training Program, King Faisal Specialist Hospital and Research in Riyadh, Riyadh, Saudi Arabia
3 Medical Students, Alfaisal University, Riyadh, Saudi Arabia

Correspondence Address:
Dr. Rawan Salem Alayed
14215, Riyadh
Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/sjoh.sjoh_20_21

Rights and Permissions

Objective: This study aims to look at bone marrow failure disease patients who presented to our center, as to analyze the presentation and possible ways to improve the survival outcome in these cases. Methods: This was a retrospective chart review study. Results: In our series, most of the head-and-neck squamous cell carcinomas (HNSCCs) were found in Fanconi anemia (FA) patients, and most are located within the oral cavity, most frequently at the tongue margins and the gingival areas. These tumors arise in both male and female bone marrow failure disease patients without a prior history of excessive tobacco and alcohol use. Even if a patient presents at an early stage, there are frequent relapses. The highly aggressive nature of the tumors is reflected by poor survival, amounting to <2 years. FA is a rare but well-studied inherited disorder that is clinically characterized by progressive bone marrow failure, congenital malformations, and increased incidence of malignancies, especially acute myeloid leukemia and squamous cell carcinomas (SSCs) of the head and neck. Greatly improved protocols for stem cell transplantation increasingly save the lives of these young patients. However, in both transplanted and not transplanted patients, the emergence of aggressive SSC represents a major medical challenge. Noninvasive screening options, including frequent self-examination and inspection by a medical team, should lead to early detection and treatment. Standard platinum-based chemotherapy in combination with radiotherapy cannot be used in FA patients due to therapy-associated toxicities and mortalities even with reduced dosing. Therefore, surgery is the most important treatment option for HNSCC in bone marrow failure disease patients and requires an early and efficient detection of malignant lesions. Conclusion: So far, no uniform treatment protocol for the management of HNSCCs in FA patients exists. Therefore, we propose that the information on affected FA patients should be collected worldwide, practical therapeutic guidelines developed and national treatment centers established.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed452    
    Printed14    
    Emailed0    
    PDF Downloaded37    
    Comments [Add]    

Recommend this journal